Novartis AG (NYSE:NVS) Q4 2025 earnings call transcript

Novartis AG (NYSE:NVS) Q4 2025 Earnings Call Transcript February 4, 2026 Novartis AG beats earnings expectations. Reported ...

Novartis Pharma AG: Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance ...
The Clinton Herald

TO YOUR GOOD HEALTH: Urologist suggests chemo prior to surgery for man with cancer

DEAR DR. ROACH: I am an 82-year old man who was in good health until I found out that I have an issue in my left kidney. My ...
Kauppalehti

Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025

Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong ...